These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

403 related items for PubMed ID: 27306785

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.
    Monti D, Saccomani L, Chetoni P, Burgalassi S, Tampucci S, Mailland F.
    Br J Dermatol; 2011 Jul; 165(1):99-105. PubMed ID: 21410668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ciclopirox delivery into the human nail plate using novel lipid diffusion enhancers.
    Hafeez F, Hui X, Selner M, Rosenthal B, Maibach H.
    Drug Dev Ind Pharm; 2014 Jun; 40(6):838-44. PubMed ID: 23600655
    [Abstract] [Full Text] [Related]

  • 6. Hydrosoluble medicated nail lacquers: in vitro drug permeation and corresponding antimycotic activity.
    Monti D, Saccomani L, Chetoni P, Burgalassi S, Senesi S, Ghelardi E, Mailland F.
    Br J Dermatol; 2010 Feb 01; 162(2):311-7. PubMed ID: 19886884
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro permeation and penetration of ciclopirox olamine from poloxamer 407-based formulations--comparison of isolated human stratum corneum, bovine hoof plates and keratin films.
    Täuber A, Müller-Goymann CC.
    Int J Pharm; 2015 Jul 15; 489(1-2):73-82. PubMed ID: 25895717
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ciclopirox nail lacquer topical solution 8% in the treatment of toenail onychomycosis.
    Gupta AK, Fleckman P, Baran R.
    J Am Acad Dermatol; 2000 Oct 15; 43(4 Suppl):S70-80. PubMed ID: 11051136
    [Abstract] [Full Text] [Related]

  • 11. Ciclopirox nail lacquer: a brush with onychomycosis.
    Gupta AK.
    Cutis; 2001 Aug 15; 68(2 Suppl):13-6. PubMed ID: 11665723
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A-Detail fact sheet (Canada). Ciclopirox 8% nail lacquer (Penlac).
    Skin Therapy Lett; 2001 Aug 15; 10(10):suppl 1 p.. PubMed ID: 16518906
    [No Abstract] [Full Text] [Related]

  • 16. Ciclopirox delivery into the human nail plate.
    Hui X, Wester RC, Barbadillo S, Lee C, Patel B, Wortzmman M, Gans EH, Maibach HI.
    J Pharm Sci; 2004 Oct 15; 93(10):2545-8. PubMed ID: 15349963
    [Abstract] [Full Text] [Related]

  • 17. Ciclopirox and Efinaconazole Transungual Permeation, Antifungal Activity, and Proficiency To Induce Resistance in Trichophyton rubrum.
    Monti D, Mazzantini D, Tampucci S, Vecchione A, Celandroni F, Burgalassi S, Ghelardi E.
    Antimicrob Agents Chemother; 2019 Oct 15; 63(10):. PubMed ID: 31332076
    [Abstract] [Full Text] [Related]

  • 18. Ciclopirox nail lacquer for the treatment of onychomycosis: an open non-comparative study.
    Shemer A, Nathansohn N, Trau H, Amichai B, Grunwald MH.
    J Dermatol; 2010 Feb 15; 37(2):137-9. PubMed ID: 20175847
    [Abstract] [Full Text] [Related]

  • 19. Ciclopirox nail lacquer 8%: in vivo penetration into and through nails and in vitro effect on pig skin.
    Ceschin-Roques CG, Hänel H, Pruja-Bougaret SM, Luc J, Vandermander J, Michel G.
    Skin Pharmacol; 1991 Feb 15; 4(2):89-94. PubMed ID: 1831626
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.